Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa
Objectives Locally led research on cancer is needed in sub-Saharan Africa to set feasible research priorities that inform national policy. The aim of this project was to develop a research agenda for national cancer control planning, using a nationally driven approach, focused on barriers to diagnos...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | BMJ Oncology |
| Online Access: | https://bmjoncology.bmj.com/content/3/1/e000172.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832582034350931968 |
|---|---|
| author | Ajay Aggarwal Janet Seeley Virginia Bond Kennedy Lishimpi John Kachimba Musonda Simwinga Andrew Sentoogo Ssemata Susan Msadabwe Dorothy Chilambe Lombe Monde Mwamba Richard Muhumuza Victor Mapulanga |
| author_facet | Ajay Aggarwal Janet Seeley Virginia Bond Kennedy Lishimpi John Kachimba Musonda Simwinga Andrew Sentoogo Ssemata Susan Msadabwe Dorothy Chilambe Lombe Monde Mwamba Richard Muhumuza Victor Mapulanga |
| author_sort | Ajay Aggarwal |
| collection | DOAJ |
| description | Objectives Locally led research on cancer is needed in sub-Saharan Africa to set feasible research priorities that inform national policy. The aim of this project was to develop a research agenda for national cancer control planning, using a nationally driven approach, focused on barriers to diagnosis and high-quality treatment for prostate cancer in Zambia.Methods and analysis This was a Delphi process. 29 stakeholders were scored barriers on feasibility, the proportion of patients affected, the impact on patient outcomes and if there was a potential to address health systems barriers meaningfully. There were three rounds (R) to the process: (R1 and R2) by electronic survey and (R3) in-person meeting. In R1 statements scoring above 15 from over 70% of participants were prioritised immediately for R3 discussion. Those scoring below 30% were dropped and those in between were re-surveyed in R2.Results 22 and 17 of the 29 stakeholders responded to R1 and R2. 14 stakeholders attended R3. National priority research areas for prostate cancer in Zambia were identified as prostate cancer awareness; building affordable high-quality diagnostic capacity; affordability of specialist cancer treatments; supporting better access to medicines; delivery and coordination of services across the pathway and staff training.Conclusion The suggested seven priority areas allow for the development of the prostate cancer control programme to be conducted in a holistic manner. The expectation is with this guidance international partners can contribute within the frameworks of the local agenda for sustainable development to be realised. |
| format | Article |
| id | doaj-art-7e15e2288f4f47678d1ab6ea3f3b5a5e |
| institution | Kabale University |
| issn | 2752-7948 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Oncology |
| spelling | doaj-art-7e15e2288f4f47678d1ab6ea3f3b5a5e2025-01-30T06:20:09ZengBMJ Publishing GroupBMJ Oncology2752-79482024-07-013110.1136/bmjonc-2023-000172Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan AfricaAjay Aggarwal0Janet Seeley1Virginia Bond2Kennedy Lishimpi3John Kachimba4Musonda Simwinga5Andrew Sentoogo Ssemata6Susan Msadabwe7Dorothy Chilambe Lombe8Monde Mwamba9Richard Muhumuza10Victor Mapulanga11Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UKDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UKZambart, School of Public Health, Ridgeway Campus, University of Zambia, Lusaka, ZambiaDepartment of Clinical Oncology, Cancer Diseases Hospital, Lusaka, ZambiaDepartment of Surgery, Livingstone General Hospital, Lusaka, ZambiaZambart, School of Public Health, Ridgeway Campus, University of Zambia, Lusaka, ZambiaThe Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebe, UgandaDepartment of Clinical Oncology, Cancer Diseases Hospital, Lusaka, ZambiaDepartment of Radiation Oncology, MidCentral District Health Board, Palmerston North, New ZealandZambart, School of Public Health, Ridgeway Campus, University of Zambia, Lusaka, ZambiaThe Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Uganda Research Unit, Entebe, UgandaDepartment of Surgery, Adult Hospital University Teaching Hospitals, Lusaka, ZambiaObjectives Locally led research on cancer is needed in sub-Saharan Africa to set feasible research priorities that inform national policy. The aim of this project was to develop a research agenda for national cancer control planning, using a nationally driven approach, focused on barriers to diagnosis and high-quality treatment for prostate cancer in Zambia.Methods and analysis This was a Delphi process. 29 stakeholders were scored barriers on feasibility, the proportion of patients affected, the impact on patient outcomes and if there was a potential to address health systems barriers meaningfully. There were three rounds (R) to the process: (R1 and R2) by electronic survey and (R3) in-person meeting. In R1 statements scoring above 15 from over 70% of participants were prioritised immediately for R3 discussion. Those scoring below 30% were dropped and those in between were re-surveyed in R2.Results 22 and 17 of the 29 stakeholders responded to R1 and R2. 14 stakeholders attended R3. National priority research areas for prostate cancer in Zambia were identified as prostate cancer awareness; building affordable high-quality diagnostic capacity; affordability of specialist cancer treatments; supporting better access to medicines; delivery and coordination of services across the pathway and staff training.Conclusion The suggested seven priority areas allow for the development of the prostate cancer control programme to be conducted in a holistic manner. The expectation is with this guidance international partners can contribute within the frameworks of the local agenda for sustainable development to be realised.https://bmjoncology.bmj.com/content/3/1/e000172.full |
| spellingShingle | Ajay Aggarwal Janet Seeley Virginia Bond Kennedy Lishimpi John Kachimba Musonda Simwinga Andrew Sentoogo Ssemata Susan Msadabwe Dorothy Chilambe Lombe Monde Mwamba Richard Muhumuza Victor Mapulanga Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa BMJ Oncology |
| title | Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa |
| title_full | Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa |
| title_fullStr | Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa |
| title_full_unstemmed | Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa |
| title_short | Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa |
| title_sort | defining national research priorities for prostate cancer in zambia using the delphi process for comprehensive cancer policy setting in sub saharan africa |
| url | https://bmjoncology.bmj.com/content/3/1/e000172.full |
| work_keys_str_mv | AT ajayaggarwal definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT janetseeley definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT virginiabond definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT kennedylishimpi definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT johnkachimba definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT musondasimwinga definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT andrewsentoogossemata definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT susanmsadabwe definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT dorothychilambelombe definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT mondemwamba definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT richardmuhumuza definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica AT victormapulanga definingnationalresearchprioritiesforprostatecancerinzambiausingthedelphiprocessforcomprehensivecancerpolicysettinginsubsaharanafrica |